Left atrial dilatation: A target organ damage in young to middle-age hypertensive patients. The Campania Salute Network.

[1]  G. de Simone,et al.  Determinants of decline of renal function in treated hypertensive patients: the Campania Salute Network , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  G. de Simone,et al.  Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network , 2018, European Journal of Preventive Cardiology.

[3]  G. de Simone,et al.  Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). , 2017, International journal of cardiology.

[4]  B. Howard,et al.  Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study). , 2017, The American journal of cardiology.

[5]  G. de Simone,et al.  Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long‐Axis View , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  G. de Simone,et al.  Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network) , 2017, Journal of the American Heart Association.

[7]  Pablo Lamata,et al.  Novel Computational Analysis of Left Atrial Anatomy Improves Prediction of Atrial Fibrillation Recurrence after Ablation , 2017, Frontiers in physiology.

[8]  G. de Simone,et al.  Obesity and hypertensive heart disease: focus on body composition and sex differences , 2016, Diabetology & Metabolic Syndrome.

[9]  G. de Simone,et al.  Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network. , 2016, American journal of hypertension.

[10]  G. de Simone,et al.  Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy , 2016, Journal of hypertension.

[11]  J. Staessen,et al.  Impact and pitfalls of scaling of left ventricular and atrial structure in population-based studies , 2016, Journal of hypertension.

[12]  G. de Simone,et al.  Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute Network , 2016, Journal of hypertension.

[13]  G. de Simone,et al.  Development of new atherosclerotic plaque in hypertensive patients: an observational registry study from the Campania-Salute network , 2015, Journal of hypertension.

[14]  G. de Simone,et al.  Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network. , 2015, International journal of cardiology.

[15]  Melbourne,et al.  Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  T. Gillebert,et al.  Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. , 2015, European heart journal cardiovascular Imaging.

[17]  N. Freemantle,et al.  Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. , 2015, JACC. Cardiovascular imaging.

[18]  C. Lewis,et al.  Left atrial dimension and traditional cardiovascular risk factors predict 20-year clinical cardiovascular events in young healthy adults: the CARDIA study. , 2014, European heart journal cardiovascular Imaging.

[19]  B. Hoit.  Left atrial size and function: role in prognosis. , 2014, Journal of the American College of Cardiology.

[20]  G. de Simone,et al.  Hypertensive target organ damage predicts incident diabetes mellitus , 2013, European heart journal.

[21]  E. Gerdts.  Left atrial enlargement – A prevalent marker of hypertensive heart disease , 2012, Blood pressure.

[22]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[23]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[24]  G. Mancia,et al.  2007 ESH–ESC practice guidelines for the management of arterial hypertension , 2008 .

[25]  R. Devereux,et al.  Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial , 2007, Hypertension.

[26]  C. Zoccali,et al.  Left atrial volume in end-stage renal disease: a prospective cohort study , 2006, Journal of hypertension.

[27]  R. Devereux,et al.  Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). , 2006, American heart journal.

[28]  J. Seward,et al.  Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function. , 2005, The American journal of cardiology.

[29]  A. Zanchetti,et al.  Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals , 2005, Journal of hypertension.

[30]  Douglas W Mahoney,et al.  Diastolic dysfunction and left atrial volume: a population-based study. , 2005, Journal of the American College of Cardiology.

[31]  M. Nieminen,et al.  Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.

[32]  G. Cioffi,et al.  Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension , 2004, Journal of hypertension.

[33]  James B Seward,et al.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. , 2002, The American journal of cardiology.

[34]  R. Devereux,et al.  Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension , 2002, Journal of hypertension.

[35]  Richard B. Devereux,et al.  Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study , 2002, Hypertension.

[36]  N. Schiller,et al.  Best method in clinical practice and in research studies to determine left atrial size. , 1999, The American journal of cardiology.

[37]  G. de Simone,et al.  Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography. , 1996, The American journal of cardiology.

[38]  R B D'Agostino,et al.  Left atrial size and the risk of stroke and death. The Framingham Heart Study. , 1995, Circulation.

[39]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[40]  M. Alderman,et al.  Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events , 1993, Circulation.

[41]  B. Trimarco,et al.  Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network , 2017, Journal of Human Hypertension.

[42]  B. Trimarco,et al.  Prognostic value of combined target-organ damage in patients with essential hypertension. , 2015, American journal of hypertension.

[43]  Zhao-fang Yin,et al.  Left atrial diameter, flow-mediated dilation of brachial artery and target organ damage in Chinese patients with hypertension , 2012, Journal of Human Hypertension.

[44]  T. Manolio,et al.  Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study). , 2006, The American journal of cardiology.